Anika Therapeutics (ANIK) Cash from Operations (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Cash from Operations of 684000.0 for Q2 2026, down 261.9% year-over-year from 422470.59 in Q2 2025, and up 85.89% quarter-over-quarter from 4846000.0 in Q1 2026.
Anika Therapeutics (ANIK) Cash from Operations (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Cash from Operations for 17 consecutive years, with 684000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Operations fell 261.9% year-over-year to 684000.0; the TTM figure through Jun 2026 stood at 5977000.0 (down 4.81% YoY), while the FY2025 annual figure was 11188000.0, up 107.07% from the prior year.
- Cash from Operations climbed to 684000.0 in Q2 2026 per ANIK's latest filing, from 4846000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 6870000.0 in Q3 2025 and bottomed at 8293000.0 in Q2 2023.
- Historically, Cash from Operations has averaged 760111.11 across 5 years, with a median of 177500.0 in 2022.
- Annual changes were most pronounced in 2023 — Cash from Operations soared 656.34% — and 2026, when it plunged 3627.69%.
- Anika Therapeutics' Cash from Operations stood at 481000.0 in 2022, then jumped by 656.34% to 3638000.0 in 2023, then plunged by 56.51% to 1582000.0 in 2024, then jumped by 193.11% to 4637000.0 in 2025, then slumped by 114.75% to 684000.0 in 2026.
- Business Quant data shows ANIK's Cash from Operations at 684000.0 in Q2 2026, 4846000.0 in Q1 2026, and 4637000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Anika Therapeutics | 285.40 Mn | 246.98 Mn | 21.24 Mn | -684,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -684,000.00 |
| Jun 30, 2026 | -684,000.00 |
| Mar 31, 2026 | -4.85 Mn |
| Mar 31, 2026 | -4.85 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Sep 30, 2025 | 6.87 Mn |
| Sep 30, 2025 | 6.87 Mn |
| Jun 30, 2025 | -189,000.00 |
| Jun 30, 2025 | -189,000.00 |
| Mar 31, 2025 | -130,000.00 |
| Mar 31, 2025 | -130,000.00 |
| Dec 31, 2024 | 1.58 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Sep 30, 2024 | 5.02 Mn |
| Sep 30, 2024 | 5.02 Mn |
| Jun 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | -1.07 Mn |
| Mar 31, 2024 | -126,000.00 |
| Mar 31, 2024 | -126,000.00 |